Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.559
Filter
1.
Rev. colomb. gastroenterol ; 36(supl.1): 78-84, abr. 2021. graf
Article in Spanish | LILACS | ID: biblio-1251552

ABSTRACT

Resumen Introducción: El mejor tratamiento para los tumores neuroendocrinos es la resección completa del tumor, los ganglios, e inclusive en casos seleccionados, las metástasis a distancia. En ocasiones, el tumor primario es pequeño y de difícil localización preoperatoria o sus recaídas pueden ser difíciles de localizar en el terreno de fibrosis por cirugías o tratamientos previos. La cirugía radioguíada ofrece una opción adicional de localización intraoperatoria que hasta ahora no ha sido muy utilizada en tumores neuroendocrinos. Presentación del caso: Paciente de 59 años con antecedente de resección atípica de duodeno y páncreas por tumor neuroendocrino grado 2 del duodeno un año antes. En la tomografía por emisión de positrones/tomografía computarizada (PET/CT) 68Ga-DOTANOC se encontró un ganglio con sobreexpresión de receptores de somatostatina en el mesenterio, sin otras lesiones a distancia. Por los antecedentes quirúrgicos y la dificultad de visualizar la lesión en las imágenes anatómicas (resonancia magnética [RM]) se decidió realizar la cirugía radioguíada. En el preoperatorio se administraron 15 mCi de tecnecio 99 metaestable-hidrazinonicotinilo-Tyr3-octreotida (99mTc-HYNIC-TOC) y se verificó la buena captación en el ganglio. En cirugía, luego de la disección inicial se utilizó la sonda gamma, que detectó una actividad 5 veces mayor en el ganglio, comparado con los tejidos vecinos, lo que permitió su localización y resección. La evolución fue adecuada y un año después no hay evidencia de recaídas. Conclusión: La cirugía radioguíada no ha sido muy utilizada en la localización intraoperatoria de tumores neuroendocrinos, pero es una buena alternativa en casos seleccionados, como el presentado en este artículo, y permite la detección intraoperatoria y su resección completa.


Abstract Introduction: The best treatment for neuroendocrine tumors is complete resection of the tumor, lymph nodes, and even distant metastases in selected cases. Sometimes, the primary tumor is small and difficult to detect before surgery, or its relapses may be difficult to locate in the fibrosis field due to previous surgeries or treatments. Although radioguided surgery allows for additional intraoperative localization, it has yet to be widely used in neuroendocrine tumors. Case report: A 59-year-old patient with a history of atypical resection of duodenum and pancreas due to grade 2 neuroendocrine tumor of the duodenum one year earlier. On 68Ga-DOTANOC PET/CT, a node with somatostatin receptor overexpression was found in the mesentery, with no other distant lesions. Due to the surgical history and the difficulty in visualizing the lesion on anatomical images (MRI), it was decided to perform the radioguided surgery. During the preoperative period, 15 mCi of 99mTc-HYNIC-TOC were administered verifying good uptake in the ganglion. Following the initial dissection, a gamma probe was used, detecting 5 times more activity in the ganglion than in adjacent tissues, allowing for localization and resection. The patient's progress was satisfactory, and one year later there is no evidence of relapse. Conclusion: Although radioguided surgery is not commonly used in the intraoperative location of neuroendocrine tumors, it is a viable option in some situations, such as the one presented here, because it allows for intraoperative detection and full resection.


Subject(s)
Humans , Male , Middle Aged , Somatostatin , Tomography, X-Ray Computed , Neuroendocrine Tumors , Positron-Emission Tomography , Probe
2.
Article in Chinese | WPRIM | ID: wpr-880462

ABSTRACT

In this study, through the analysis of the composition of domestic large radioactive medical equipment PET/CT and the characteristics of each subsystem, combing the vulnerable spots, according to the standard requirements of PET/CT for 10 years in its service life, we research the PET/CT service life's effectiveness. Firstly, this study introduces the concept of service life, the relationship between service life and risk analysis, the pivotal system composition of PET/CT, the importance of reliability of each component, the traditional test method to verify its reliability is researched. This study suggests a test procedure and method to prove the reliability of various components of PET/CT equipment during the service life. This method is described in detail, and the specific test process in practical engineering application is discussed, which proves that it is beneficial to ensure the effectiveness of PET/CT during the service life.


Subject(s)
Positron Emission Tomography Computed Tomography , Positron-Emission Tomography , Reproducibility of Results , Tomography, X-Ray Computed
3.
Article in Chinese | WPRIM | ID: wpr-879290

ABSTRACT

Because of the unobvious early symptoms and low 5-year survival rate, the early diagnosis and treatment is of great significance for patients with non-small cell lung cancer. Glucose transporter-1 is the most widely distributed glucose transporters in various tissue cells in the human body, whose expression in non-small cell lung cancer is closely related to the histological types, lymph node metastasis, degree of differentiation, progression and prognosis.


Subject(s)
Carcinoma, Non-Small-Cell Lung/diagnostic imaging , Fluorodeoxyglucose F18 , Glucose Transport Proteins, Facilitative , Glucose Transporter Type 1 , Humans , Lung Neoplasms/diagnostic imaging , Positron Emission Tomography Computed Tomography , Positron-Emission Tomography , Radiopharmaceuticals
5.
Rev. cuba. inform. méd ; 12(2): e394, tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1144459

ABSTRACT

En radiología se utilizan varias técnicas imagenológicas para el diagnóstico de enfermedades y la asistencia en intervenciones quirúrgicas con el objetivo de determinar la ubicación y dimensión exacta de un tumor cerebral. Técnicas como la Tomografía por Emisión de Positrones y la Resonancia Magnética permiten determinar la naturaleza maligna o benigna de un tumor cerebral y estudiar las estructuras del cerebro con neuroimágenes de alta resolución. Investigadores a nivel internacional han utilizado diferentes técnicas para la fusión de la Tomografía por Emisión de Positrones y Resonancia Magnética al permitir la observación de las características fisiológicas en correlación con las estructuras anatómicas. La presente investigación tiene como objetivo elaborar un proceso para la fusión de neuroimágenes de Tomografía por Emisión de Positrones y Resonancia Magnética. Para ello se definieron 5 actividades en el proceso y los algoritmos a utilizar en cada una, lo cual propició identificar los más eficientes para aumentar la calidad en el proceso de fusión. Como resultado se obtuvo un proceso de fusión de neuroimágenes basado en un esquema híbrido Wavelet y Curvelet que garantiza obtener imágenes fusionadas de alta calidad(AU)


In radiology, various imaging techniques are used for the diagnosis of diseases and assistance in surgical interventions with the aim of determining the exact location and dimension of a brain tumor. Techniques such as Positron Emission Tomography and Magnetic Resonance can determine the malignant or benign nature of a brain tumor and study brain structures with high-resolution neuroimaging. International researchers have used different techniques for the fusion of Positron Emission Tomography and Magnetic Resonance, allowing the observation of physiological characteristics in correlation with anatomical structures. The present research aims to develop a process for the fusion of neuroimaging of Positron Emission Tomography and Magnetic Resonance Imaging. Five activities were defined in the process and the algorithms to be used in each one, which led identifying the most efficient ones to increase the quality in the fusion process. As a result, a neuroimaging fusion process was obtained based on a hybrid Wavelet and Curvelet scheme that guarantees high quality merged images(AU)


Subject(s)
Algorithms , Magnetic Resonance Imaging/methods , Positron-Emission Tomography/methods , Wavelet Analysis , Neuroimaging/methods , Cerebral Ventricle Neoplasms/diagnostic imaging
6.
Rev. chil. radiol ; 26(3): 105-112, set. 2020. ilus
Article in Spanish | LILACS | ID: biblio-1138704

ABSTRACT

Resumen: Las crecientes cifras mundiales de prevalencia e incidencia de la Enfermedad de Alzheimer exigen el desarrollo de métodos diagnósticos cada vez más precoces. La enfermedad suele diagnosticarse cuando la patología ya está avanzada y poco se puede hacer terapéuticamente, conllevando una gran pérdida de años de vida y altos costos sociales y familiares. Considerando esta patología como una disrupción a gran escala de las redes neuronales del cerebro humano, distintos estudios han propuesto biomarcadores basados en resonancia magnética y tomografía por emisión de positrones. El presente artículo revisa sistemáticamente dichos estudios considerando un abordaje desde la ciencia de redes neuronales.


Abstract: The increased global prevalence and incidence of Alzheimer's Disease demands the development of early diagnostic methods. This disease is usually diagnosed when the pathology is already advanced and therapeutically, there's not much to do, leading to a great loss of years of life, high socials and family costs. Considering this pathology as a large-scale disruption of neural networks of the human brain, different studies have proposed biomarkers based on functional magnetic resonance imaging and positron emission tomography. This article systematically reviews these studies considering an approach of neural networks science.


Subject(s)
Humans , Biomarkers , Alzheimer Disease/diagnostic imaging , Magnetic Resonance Spectroscopy , Positron-Emission Tomography , Neuroimaging
7.
Rev. argent. radiol ; 84(3): 85-92, ago. 2020. tab, graf, il.
Article in Spanish | LILACS | ID: biblio-1143920

ABSTRACT

Resumen Objetivo: El objetivo de este estudio es evaluar la relación de las cinéticas del antígeno prostático específico (PSA por su sigla en inglés) con la positividad de la tomografía por emisión de positrones/tomografía computada [PET/TC colina (PETC)]en pacientes con una recaída de cáncer de próstata (RCP). Materiales y métodos: Se realizó un trabajo retrospectivo de 48 pacientes con RCP post prostatectomía radical (PR) evaluados con PETC. Resultados: La PETC negativa tuvo una mediana de 16,3 meses y la PETC positiva de 5,5 meses (p = < 0,001) para el tiempo de doblaje de PSA (PSADT por su sigla en inglés); la PETC fue positiva en el 96% de los pacientes con un PSADT< 12 meses. La PETC negativa tuvo una mediana de 0,03 ng/ml/año y la PETC positiva de 4,1 ng/ml/año (p = < 0,001) para la velocidad del PSA (PSAVpor su sigla en inglés); la PETC fue positiva en el 92% de los pacientes con un PSAV > 0,75 ng/ml/año. Las áreas bajo la curva ROC para PSAV fue de 0,984 con un punto de corte de mayor discriminación de 0.785 ng/ml/año, mostrando razones de verosimilitud (LR por su sigla en inglés) LR + = 25 y LR- = 0,1. Para PSADT el ROC fue de 0,992 con un punto de corte de mayor discriminación de 11 meses, mostrando LR + = 11 y LR- = 0. Discusión: El PSA es un indicador inespecífico de PETC positiva. Un estudio inicial demostró que los pacientes con una RCP con una PETC positiva tenían un menor PSADT y una mayor PSAV que los pacientes con una PETC negativa. Conclusión: La positividad de la PETC se vio influenciada por las cinéticas del PSA, observándose que a menor PSADT y que a mayor PSAV mayor fue la probabilidad de la positividad de la PETC.


Abstract Purpose: The aim of this study is to evaluate the relationship between Prostate-Specific Antigen (PSA) kinetics and the detection of Prostate Cancer Relapse (PCR) with Positron-Emission Tomography (PETC). Material and methods: A retrospective study of 48 patients with a PCR after a radical prostatectomy evaluated with PETC was performed. Results: PSA Doubling Time (PSADT), with negative PETC, had a median of 16.3 months and the positive PETC a median of 5.5 months (p = < 0.001); 96% of patients with a PSADT <12 months had positive PETC. PSA Velocity (PSAV), negative PETC, had a median of 0.03 ng/ml/year and positive PETC a median of 4.1 ng/ml/year (p = < 0.001); 92% of patients who had a PSAV > 0.75 ng/ml/year had positive PETC. The ROC for PSAV was 0.984 with a cut-off value of 0.785 ng/ml/year, Showing Likelihood Ratios (LR) LR + = 25 and LR- = 0.1. The ROC for PSADT was 0.992 with a cut off value of 11 months, showing LR + = 11 and LR- = 0. Discussion: PSA is a nonspecific indicator of positive PETC. An initial study demon-strated that patients with a PCR and positive PETC had lower PSADT and higher PSAV than patients with a negative PETC. Conclusion: The rate of detection of PCR with PETC was influenced by the kinetics of PSA, and it was observed that the lower the PSADT and the higher the PSAV, the greater the probability of the positivity of the PETC.


Subject(s)
Humans , Male , Aged , Prostatic Neoplasms/diagnostic imaging , Prostate-Specific Antigen/pharmacokinetics , Neoplasm Recurrence, Local/diagnostic imaging , Prostatic Neoplasms/physiopathology , Tomography, X-Ray Computed/methods , Cross-Sectional Studies , Retrospective Studies , Prostate-Specific Antigen/blood , Positron-Emission Tomography/methods
8.
Rev. cuba. inform. méd ; 12(1)ene.-jun. 2020. tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1126554

ABSTRACT

Técnicas como la Tomografía por Emisión de Positrones y la Tomografía Computarizada permiten determinar la naturaleza maligna o benigna de un tumor y estudiar las estructuras anatómicas del cuerpo con imágenes de alta resolución, respectivamente. Investigadores a nivel internacional han utilizado diferentes técnicas para la fusión de la Tomografía por Emisión de Positrones y la Tomografía Computarizada porque permite observar las funciones metabólicas en correlación con las estructuras anatómicas. La presente investigación se propone realizar un análisis y selección de algoritmos que propicien la fusión de neuroimágenes, basado en la precisión de los mismos. De esta forma contribuir al desarrollo de software para la fusión sin necesidad de adquirir los costosos equipos de adquisición de imágenes de alto rendimiento, los cuales son costosos. Para el estudio se aplicaron los métodos Análisis documental, Histórico lógico e Inductivo deductivo. Se analizaron e identificaron las mejores variantes de algoritmos y técnicas para la fusión según la literatura reportada. A partir del análisis de estas técnicas se identifica como mejor variante el esquema de fusión basado en Wavelet para la fusión de las imágenes. Para el corregistro se propone la interpolación Bicúbica. Como transformada discreta de Wavelet se evidencia el uso de la de Haar. Además, la investigación propició desarrollar el esquema de fusión basado en las técnicas anteriores. A partir del análisis realizado se constataron las aplicaciones y utilidad de las técnicas de fusión como sustitución a los altos costos de adquisición de escáneres multifunción PET/CT para Cuba(AU)


Techniques such as Positron Emission Tomography and Computed Tomography allow to determine the malignant or benign nature of a tumor and to study the anatomical structures of the body with high resolution images, respectively. International researchers have used different techniques for the fusion of Positron Emission Tomography and Computed Tomography because it allows observing metabolic functions in correlation with anatomical structures. The present investigation proposes to carry out an analysis and selection of algorithms that favor the fusion of neuroimaging, based on their precision. In this way, contribute to the development of fusion software without the need to purchase expensive high-performance imaging equipment, which is expensive. For the study the documentary analysis, logical historical and deductive inductive methods were applied. The best algorithm variants and techniques for fusion were analyzed and identified according to the reported literature. From the analysis of these techniques, the Wavelet-based fusion scheme for image fusion is identified as the best variant. Bicubic interpolation is proposed for co-registration. As a discrete Wavelet transform, the use of Haar's is evidenced. In addition, the research led to the development of the fusion scheme based on the previous techniques. From the analysis carried out, the applications and usefulness of fusion techniques were verified as a substitute for the high costs of acquiring PET / CT multifunction scanners for Cuba(AU)


Subject(s)
Image Processing, Computer-Assisted/methods , Software/standards , Tomography, X-Ray Computed/methods , Positron-Emission Tomography/methods , Wavelet Analysis , Cuba
9.
Rev. argent. cir ; 112(1): 51-54, mar. 2020. ilus
Article in English, Spanish | LILACS | ID: biblio-1125781

ABSTRACT

El schwannoma es un tumor neurogénico que se presenta más frecuentemente en el ángulo costovertebral del mediastino posterior, pero también en otras localizaciones dentro del tórax. Habitualmente suele ser una masa única, encapsulada, bien definida, con un tamaño aproximado 2 a 10 cm. Presentamos el caso de un paciente de 66 años, derivado a nuestro hospital por una masa de 13 cm localizada en el hemitórax inferior izquierdo. Se realizó una biopsia, y la resonancia magnética corroboró el diagnóstico de un tumor mediastínico gigante de la vaina neural. Se procedió a su resección completa sin complicaciones.


Schwannomas are neurogenic tumors, commonly located in the costovertebral angle of the posterior mediastinum, but with many intrathoracic locations. They usually present as a solitary, well-circumscribed and encapsulated mass with a size between 2 and 10 cm. We report a case of a 66-year-old male, referred to our hospital for a mass located at the left lower hemithorax with 13 cm in size. A percutaneous biopsy was performed, and magnetic resonance imaging confirmed the diagnosis of a resectable giant mediastinal nerve sheath tumor. Surgery was performed without complications.


Subject(s)
Humans , Male , Aged , Lung Neoplasms/pathology , Neurilemmoma/diagnostic imaging , Thorax/diagnostic imaging , Thoracotomy , Magnetic Resonance Spectroscopy/methods , Positron-Emission Tomography/methods , Electrocardiography
10.
Rev. argent. cir ; 112(1): 58-62, mar. 2020. tab
Article in English, Spanish | LILACS | ID: biblio-1125783

ABSTRACT

La ascitis quilosa posoperatoria (AQP) se debe a acumulación de líquido rico en triglicéridos en la cavidad peritoneal tras una lesión en la cisterna del quilo o en sus afluentes. Es infrecuente verla después de una hepatectomía. Se presenta el caso de un varón de 44 años con adenocarcinoma a 16 cm del margen anal T3N1, con metástasis que ocupaba casi la totalidad del lóbulo hepático derecho. Luego de quimioterapia se realizó hepatectomía derecha, observándose al cuarto día postoperatorio líquido del drenaje endotorácico de aspecto lechoso, con triglicéridos 223 mg/dL y 77 mg/dL de triglicéridos séricos. Se inició dieta sin grasas, hiperproteica, con ácidos grasos de cadena media y octreótide (100 microgramos subcutáneos cada 8 horas), con resolución del cuadro. En conclusión, la complicación quilosa puede tratarse exitosamente con un abordaje menos agresivo, sin suprimir la ingesta oral, utilizando octreótide subcutáneo, dieta exenta de grasas, suplementada con proteínas y ácidos grasos de cadena media.


Postoperative chylous ascites is an intraperitoneal collection of lymphatic fluid enriched with long-chain triglycerides that results from injury of the cisterna chyli or its main tributaries. This complication is rare after liver resections. Here, we report on the case of a 44 year-old man with a T3N1 rectal adenocarcinoma 16 cm above the anal margin, with metastatic compromise of almost the entire right liver lobe. Following chemotherapy, he underwent right liver resection. On postoperative day four, the thoracic drain evidenced milky fluid containing triglyceride 223 mg/dL with serum triglycerides 77 mg/dL. A fat-free diet was indicated with fat-free protein supplements, medium chain triglycerides and octreotide (100 μg subcutaneously every 8 hours), with complete resolution. In conclusion, postoperative chylous complications may be treated successfully by a less aggressive approach, with oral diet, subcutaneous octreotide, fat-free diet supplemented with proteins and medium chain fatty acids.


Subject(s)
Humans , Male , Adult , Chylous Ascites/complications , Hepatectomy/adverse effects , Pleural Effusion/diagnostic imaging , Postoperative Complications/diagnosis , Rectal Neoplasms/surgery , Radiography, Thoracic/methods , Positron-Emission Tomography/methods
11.
J. health med. sci. (Print) ; 6(1): 17-20, ene.-mar. 2020. ilus
Article in Spanish | LILACS | ID: biblio-1096528

ABSTRACT

El síndrome de Morris es un trastorno genético recesivo ligado al cromosoma X. Se caracteriza por fenotipo femenino y cariotipo 46 XY. Las gónadas pueden estar localizadas en los labios mayores, el canal inguinal o intraabdominal. En los casos en los que la localización está en el conducto inguinal o labios mayores, las gónadas son confundidas con hernias y son extirpadas en la infancia; cuando son intraabdominales aproximadamente el 30 % tienen el riesgo de desarrollar tumores gonadales en la edad adulta, por lo que es necesario su extirpación quirúrgica. La localización de estas se realizan con ecografía, tomografía o resonancia magnética, pero en ocasiones no es posible identificar estas estructuras, es allí donde nosotros proponemos la tomografía por emisión de positrones con 18-Fluordesoxiglucosa como herramienta diagnostica para localizar el tejido gonadal, aprovechando la captación fisiológica de este radiotrazador en el tejido testicular.


Morris Syndrome is a recessive genetic disorder linked to the X chromosome. It is characterized by a feminine phenotype and 46 XY karyotype. Gonads can be localized at the upper lips and the inguinal or intra-abdominal canal. In cases where the localization can be at the inguinal conduct or upper lips, gonads are mistaken for hernias and they are removed in childhood; when they are intra-abdominal, approximately 30% has risks of developing gonadal tumors at adulthood, so is necessary its surgical removal. Their localization can be made by ultrasound scans, tomography or magnetic resonance, but sometimes is not possible to identify these structures, so this is where we propose 18-Fluorodeoxyglucose positron emission tomography as a diagnostic tool to localize the gonadal tissue, exploiting the physiological capture of this radiotracer at the testicular tissue.


Subject(s)
Humans , Male , Adult , Young Adult , Androgen-Insensitivity Syndrome/diagnostic imaging , Fluorodeoxyglucose F18 , Positron-Emission Tomography
16.
Yonsei Medical Journal ; : 257-261, 2020.
Article in English | WPRIM | ID: wpr-811469

ABSTRACT

Esthesioneuroblastoma as a source of ectopic Cushing's syndrome is rare, and to the best of our knowledge, only 20 cases have been reported worldwide. A 46-year-old healthy man visited a local clinic for general weakness and hyposmia, and underwent examination with serial endocrinological workup and brain imaging. ⁶⁸Gallium-DOTA-TOC positron emission tomography scan was helpful where diagnosis of sellar MRI and inferior petrosal sinus sampling were discordant. Combined transcranial and endoscopic endonasal approach surgery was performed, and a diagnosis of esthesioneuroblastoma was given.


Subject(s)
Cushing Syndrome , Diagnosis , Esthesioneuroblastoma, Olfactory , Humans , Magnetic Resonance Imaging , Middle Aged , Neuroimaging , Petrosal Sinus Sampling , Positron-Emission Tomography
17.
Article in English | WPRIM | ID: wpr-811194

ABSTRACT

PURPOSE: The purpose of this study was to evaluate the prognostic value of skeletal muscle depletion measured on computed tomography (CT) in patients with non-metastatic invasive breast cancer.METHODS: This retrospective study included 577 consecutive women (mean age ± standard deviation: 48.9 ± 10.2 years with breast cancer who underwent a preoperative positron-emission tomography (PET)/CT scan and curative surgery between January 2012 and August 2014. The total abdominal muscle area (TAMA), subcutaneous fat area (SFA), and visceral fat area (VFA) were measured on CT images at the L3 vertebral level. Univariate and multivariate Cox proportional-hazard regression analyses were performed to evaluate whether there was an association between sarcopenia and overall survival (OS) outcome.RESULTS: Of the 577 women, 49 (8.5%) died after a mean of 46 months. The best TAMA threshold for predicting OS was 83.7 cm². The multivariate Cox proportional-hazard analysis revealed that sarcopenia (TAMA ≤ 83.70 cm²) was a strong prognostic biomarker (hazard ratio [HR], 1.951; 95% confidence interval [CI], 1.061–3.586), along with large tumor size, axillary lymph node metastasis, high nuclear grade, estrogen receptor status, and adjuvant radiation therapy. In the subgroup analysis of patients aged ≥ 50 years, TAMA (≤ 77.14 cm²) was a significant independent factor (HR, 2.856; 95% CI, 1.218–6.695).CONCLUSION: Skeletal muscle depletion measured on CT was associated with worse OS outcome in patients with non-metastatic breast cancer.


Subject(s)
Abdominal Muscles , Breast Neoplasms , Breast , Estrogens , Female , Humans , Intra-Abdominal Fat , Lymph Nodes , Muscle, Skeletal , Neoplasm Metastasis , Positron-Emission Tomography , Retrospective Studies , Sarcopenia , Subcutaneous Fat
18.
Article in English | WPRIM | ID: wpr-880594

ABSTRACT

Small cell lung cancer belongs to neuroendocrine tumors and is the most malignant one in lung cancer. It possesses clinical features such as rapid growth, easy early metastasis, and poor prognosis. PET/CT is a molecular imaging technique that combines morphological and metabolic imaging. It has been widely used in the diagnosis, staging, treatment planning, efficacy and prognosis evaluation of tumors. This article reviews the efficacy, prognostic parameters, evaluation criteria, possible influencial factors, clinical application and value of


Subject(s)
Fluorodeoxyglucose F18 , Humans , Lung Neoplasms/pathology , Neoplasm Staging , Positron Emission Tomography Computed Tomography , Positron-Emission Tomography , Prognosis , Radiopharmaceuticals , Retrospective Studies , Small Cell Lung Carcinoma/pathology
19.
Journal of Experimental Hematology ; (6): 1189-1196, 2020.
Article in Chinese | WPRIM | ID: wpr-827141

ABSTRACT

OBJECTIVE@#To investigate the prognosis prediction value of PET/CT in DLBCL patients treated with CAR-T therapy.@*METHODS@#The effects of PET/CT were retrospectively explored on 13 R/R DLBCL patients who were treated with CAR-T therapy. Parameters reflecting tumor metabolic burden, such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured before and after CAR-T treatment.@*RESULTS@#Patients with larger baseline MTV or longer sum of longest diameters showed shorter overall survival (OS) time than those with low tumor burden. Patients achieved complete remission (CR), partial remission (PR) and minor remission (MR) determined by response evaluation criteria in lymphoma (RECIL) in 12 weeks showed progression-free survival and OS time superior to those of patients with no remission. In addition, it was found that 2 patients with residual masses classified as PR by contrast-enhanced CT of patients were evaluated as complete metabolic response by PET/CT imaging.@*CONCLUSION@#PET/CT shows a great value in the evaluation of prognosis and response in CAR-T-treated R/R DLBCL patients.


Subject(s)
Cell- and Tissue-Based Therapy , Fluorodeoxyglucose F18 , Humans , Lymphoma, Large B-Cell, Diffuse , Positron Emission Tomography Computed Tomography , Positron-Emission Tomography , Prognosis , Receptors, Chimeric Antigen , Retrospective Studies
20.
Journal of Experimental Hematology ; (6): 1267-1271, 2020.
Article in Chinese | WPRIM | ID: wpr-827128

ABSTRACT

OBJECTIVE@#To investigate the imaging characteristics of F-FDG positron emission computed tomography (F-FDG PET/CT) in multiple myeloma (MM) patients and to analyze its application value in MM and bone metastases.@*METHODS@#A retrospective analysis was made on MM patients (n=72) and bone metastases patients (n=50) admitted to Hainan Western Central Hospital from January 2017 to March 2019. All patients underwent F-FDG PET/CT examination. The distribution of lesions, bone destruction, maximum standardized uptake (SUV) and metabolic homogeneity were analyzed in both groups.@*RESULTS@#More than 80% of MM and bone metastases involved thoracic bone, spine and pelvis, followed by limbs. MM was more common in the lesions of thoracic bone and skull than those in bone metastases, the difference was statistically significant (P<0.05). The majority of MM patients presented osteolytic bone destruction (97.2%), mostly showing "insect-like phagocytic pattern", so the bone showed dilated changes, and osteogenic changes were rarely seen (2.8%). Osteolytic bone destruction accounted for 74.0% in patients with bone metastatic tumor, presenting "focal" appearance more often, and osteogenic changes accounted for 26.0%. Osteolytic bone destruction in patients with MM was significantly higher than that in patients with bone metastases(χ=14.757,P<0.05). The SUV of MM (4.25±2.16)was significantly lower than that of bone metastases (7.84±3.25) (t=6.830, P<0.05). Diffuse mild uptake of F-FDG was more common in patients with MM, and heterogeneous high uptake of F-FDG was more common in patients with bone metastasis, the difference was statistically significant (P<0.05).@*CONCLUSION@#F-FDG PET/CT examination is helpful to acquire the imaging features of bone structure and metabolic changes, and shows an important clinical value in the differential diagnosis of MM and bone metastases.


Subject(s)
Fluorodeoxyglucose F18 , Humans , Multiple Myeloma , Positron Emission Tomography Computed Tomography , Positron-Emission Tomography , Radiopharmaceuticals , Retrospective Studies , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL